Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,132	1,089	879	1,015	1,065	1,136
Market Cap Growth	93.59%	23.93%	-13.36%	-4.76%	-6.21%	10.07%
Enterprise Value	2,013	961	838	974	1,028	1,067
Last Close Price	138.00	65.66	-	-	-	-
PE Ratio	35.55	8.18	-	58.91	49.16	-
PS Ratio	11.70	4.08	9.48	9.94	16.37	18.64
PB Ratio	4.57	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	19.91	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	31.47	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	29.01	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	10.84	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	24.34	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	28.74	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	29.71	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.01	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.03	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.04	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.29	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.64	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.59	3.39	3.22	1.45	11.77	11.06
Current Ratio	3.84	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	12.34%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	6.88%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Invested Capital (ROIC)	16.65%	35.94%	-0.50%	4.68%	2.46%	0.56%
Return on Capital Employed (ROCE)	12.20%	24.90%	-0.40%	5.00%	1.40%	0.30%
Earnings Yield	2.81%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	3.18%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	1.63%	3.12%	-	-	-	-
Payout Ratio	94.36%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.65%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	-0.03%	1.18%	1.95%	2.83%	-16.81%	1.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.